Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Erratum (v52,p3014)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basu, R.
Right arrow Articles by Rizza, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basu, R.
Right arrow Articles by Rizza, R. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1738-1748, 2003
© 2003 by the American Diabetes Association, Inc.

Mechanisms of the Age-Associated Deterioration in Glucose Tolerance

Contribution of Alterations in Insulin Secretion, Action, and Clearance

Rita Basu1, Elena Breda5, Ann L. Oberg2, Claudia C. Powell2, Chiara Dalla Man5, Ananda Basu1, Janet L. Vittone3, George G. Klee4, Puneet Arora1, Michael D. Jensen1, Gianna Toffolo5, Claudio Cobelli5, and Robert A. Rizza1

1 Endocrine Research Unit, Mayo Medical School, Rochester, Minnesota
2 Department of Health Service Research, Mayo Medical School, Rochester, Minnesota
3 Department of General Internal Medicine, Mayo Medical School, Rochester, Minnesota
4 Department of Laboratory Medicine & Pathology, Mayo Medical School, Rochester, Minnesota
5 Department of Information Engineering, University of Padua, Padua, Italy


   ABSTRACT
TOP
 ABSTRACT
RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Glucose tolerance decreases with age. For determining the cause of this decrease, 67 elderly and 21 young (70.1 ± 0.7 vs. 23.7 ± 0.8 years) participants ingested a mixed meal and received an intravenous injection of glucose. Fasting glucose and the glycemic response above basal were higher in the elderly than in the young participants after either meal ingestion (P < 0.001) or glucose injection (P < 0.01). Insulin action (Si), measured with the meal and intravenous glucose tolerance test models, was highly correlated (r = 0.72; P < 0.001) and lower (P ≤ 0.002) in the elderly than in the young participants. However, when adjusted for differences in percentage body fat and visceral fat, Si no longer differed between groups. When considered in light of the degree of insulin resistance, all indexes of insulin secretion were lower (P < 0.01) in the elderly participants, indicating impaired ß-cell function. Hepatic insulin clearance was increased (P < 0.002), whereas total insulin clearance was decreased (P < 0.002) in the elderly subjects. Multivariate analysis (r = 0.70; P < 0.001) indicated that indexes of insulin action (Si) and secretion (Phitotal) but not age, peak oxygen uptake, fasting glucose, degree of fatness, or hepatic insulin clearance predicted the postprandial glycemic response. We conclude that the deterioration in glucose tolerance that occurs in healthy elderly subjects is due to a decrease in both insulin secretion and action with the severity of the defect in insulin action being explained by the degree of fatness rather than age per se.

Both diabetes and glucose intolerance are common in the elderly. The pathogenesis of carbohydrate intolerance in the elderly has been an area of active investigation. Many (1–6) but not all (7–11) studies have reported that older individuals are more insulin resistant than are younger individuals. The effect of aging on insulin secretion also has been a source of debate. Insulin secretion during a hyperglycemic clamp has been reported not to differ in elderly and young subjects (3,12,13). Conversely, insulin secretion in response to an intravenous glucose injection has been reported to be abnormal in elderly subjects in most (1,7,14) but not all (8,11) studies. In addition, there seems to be disagreement as to the cause of this abnormality. Studies have variably reported decreased early insulin secretion (14), normal early insulin secretion (8,11), or normal first-phase insulin secretion but decreased second-phase insulin secretion (1,7). Similarly, insulin concentrations after glucose ingestion have been reported to be either higher (2,15,16) or no different (4,10) in elderly and young subjects.

Many of these discrepancies may be more apparent than real. Insulin concentrations commonly have been used to assess insulin secretion (1–4,8,10,12,16,17). This introduces uncertainty because hepatic insulin extraction has been reported to change with age (7,14). Insulin secretion (18,19) and perhaps insulin action (20) are modulated by incretin hormones after glucose ingestion but not intravenous glucose injection. A variety of factors may influence insulin action and secretion, including the degree and type of obesity (21), level of fitness (22,23), and the prevailing counter insulin (e.g., glucagon, growth hormone, cortisol) hormone concentrations (24–26). In addition, the appropriateness of insulin secretion needs to be interpreted in light of the degree of insulin resistance (27–29). No difference in insulin secretion in the presence of a decrease in insulin action denotes relative ß-cell failure. A decrease in insulin secretion after intravenous injection of glucose that is not observed after ingestion of glucose suggests a compensatory effect of the gastrointestinal incretin hormones.

Androgen concentrations fall with age (30,31). It is not known whether this fall impairs carbohydrate tolerance or whether replacement of either gonadal or adrenal androgens restores glucose metabolism to normal. The present data were derived from the baseline studies of a prospective trial seeking to address this question. These data afforded us the opportunity to assess comprehensively insulin action, insulin secretion, and insulin clearance in a large number of carefully characterized healthy elderly individuals whose plasma dehydroepiandrosterone (DHEA; men and women) and testosterone (men) concentrations were in the lower range of normal relative to young individuals, reflecting the hormonal milieu that commonly occurs with "normal" aging. Results were compared with those observed in healthy young participants who were studied in an identical manner.


   RESEARCH DESIGN AND METHODS
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Participants.
After approval from the Mayo Institutional Review Board, 67 healthy elderly participants (37 elderly men and 30 elderly women) and 21 healthy young participants (11 men and 9 women) gave informed written consent to participate in the study.

Experimental design.
Studies were conducted at the Mayo General Clinical Research Center. Subjects consumed a weight maintenance diet (55% carbohydrate, 15% protein, and 30% fat) provided by the General Clinical Research Center kitchen for 3 days preceding study. All subjects were admitted at 1600 on the afternoon before study (day 1) and given a standard 10 kcal/kg meal (55% carbohydrate, 15% protein, and 30% fat), which was consumed between 1700 and 1730. No additional food was eaten until the next morning.

Mixed-meal study.
At ~0600 on the morning of day 2, an 18-G cannula was inserted in a retrograde manner into a dorsal hand vein. The hand was then placed in a heated plexibox (~55°C) to obtain arterialized venous blood samples. Another 18-G cannula was inserted in the opposite forearm for infusion of tracers to measure glucose and palmitate turnover as a separate part of the overall project. At 0900 (0 time), a mixed meal (10 kcal/kg, 45% carbohydrate, 15% protein, 40% fat) consisting of three scrambled eggs, Canadian bacon, and Jell-O (containing 1.2 g/kg body wt of dextrose) was consumed within 15 min. Blood was sampled from the arterialized venous site at -120, -30, -20, -10, 0, 5, 10, 15, 20, 30, 40, 50, 60, 75, 90, 120, 150, 180, 210, 240, 260, 280, 300, 360, and 420 min. Intravenous lines were then removed, and the participant ate lunch immediately after completion of the study (~1600–1700) and a supper at ~2000–2030.

Intravenous glucose tolerance test.
At ~0600 on the morning of day 3, an intravenous 18-G cannula was inserted into each arm. One was used for infusion of glucose, insulin, and tracers, and the other was used for withdrawal of blood. At 0900 (0 time), glucose (0.3 g/kg total body wt) was injected intravenously over 2 min followed by infusion of insulin (0.02 units/kg total body wt, begun at 20 min) given as a square wave over 5 min. Blood was sampled at -120, -30, -20, -10, 0, 2, 4, 6, 8, 10, 15, 20, 22, 25, 26, 28, 31, 35, 45, 60, 75, 90, 120, 180, and 240 min.

Analytical techniques.
Plasma samples were placed on ice, centrifuged at 4°C, separated, and stored at -20 C° until assay. Plasma glucose concentration was measured using a glucose oxidase method (YSI, Yellow Springs, OH). Plasma insulin, cortisol, and growth hormone concentrations were measured using a chemiluminescence assay with reagents obtained from Beckman (Access Assay; Beckman, Chaska, MN). Plasma glucagon and C-peptide concentrations were measured by radioimmunoassay (Linco Research, St. Louis, MO). DHEA was measured by a competitive chemiluminescent immunoassay on the Immulite automated immunoassay system (Diagnostic Products, Los Angeles, CA). Testosterone and bioavailable testosterone (Bio T) were measured in men only. Testosterone was measured using a competitive chemiluminescent immunoassay using an ACS-180 automated immunoassay system (Bayer Diagnostics, Tarrytown, NY). Bioavailable testosterone was measured by differential precipitation of sex hormone–binding globulin by ammonium sulfate after equilibration of the serum sample with tracer amounts of tritium-labeled testosterone. Palmitate concentrations were measured using high-performance liquid chromatography (32).

Body composition was measured using dual energy X-ray absorptiometry (DPX scanner; Lunar, Madison, WI). Visceral fat was measured by a single-slice computed tomographic scan at the level of L2/L3 as previously described by Jensen et al. (33). Peak oxygen uptake (VO2max) was measured using a standard treadmill stress test (34). Knee extensor strength was measured by having each participant lift a progressively higher weight using a bilateral leg press machine (Cybex, Medway, MA) until the one-repetition maximum was reached. Consecutive attempts were separated by 1 min of rest (35). Participants were familiarized with the equipment and test procedures before data collection.

Insulin action.
The index of insulin action after mixed-meal ingestion, SiMeal, was calculated using the "oral" minimal model (36,37). Model identification requires insertion of values for glucose effectiveness (Sg), glucose volume of distribution (V), the rate constant of insulin action (p2), and the fraction of ingested glucose that appears in the systemic circulation (f) (36). Sg was assumed to equal 0.014/min, V to equal 1.7 dl/kg, p2 to equal 0.03/min, and f to equal 0.87 (38). Indexes of insulin action (SiIVGTT) and glucose effectiveness (SgIVGTT) were calculated after intravenous glucose injection as previously described (39).

Insulin secretion.
Indexes of insulin secretion after mixed-meal ingestion and intravenous glucose injection were calculated as previously described by using the minimal model of C-peptide secretion and kinetics during oral (37) and intravenous glucose tests (40,41) incorporating age-associated changes in C-peptide kinetics as measured by Van Cauter et al. (42). The oral minimal model enabled calculation of Phidynamic (an index of insulin secretion in response to a change in glucose concentration), Phistatic (an index of insulin secretion in response to a given glucose concentration), and Phitotal-Meal (a global sensitivity-to-glucose index of postprandial insulin secretion). Similarly, the intravenous glucose minimal model enabled calculation of Phi1 (an index of first-phase insulin secretion), Phi2 (an index of second-phase insulin secretion), and Phitotal-IVGTT (a global sensitivity-to-glucose index of insulin secretion in response to an intravenous glucose injection). Phitotal-IVGTT was calculated from model indexes Phi1 and Phi2 by using a formula similar to the one developed for Phitotal-Meal (37).

Disposition index.
To determine whether insulin secretion was appropriate for the degree of insulin resistance, we calculated disposition indexes by multiplying the various indexes of insulin secretion by insulin sensitivity, in analogy with Bergman et al. (43). Thus, three different disposition indexes were calculated after mixed-meal ingestion, by multiplying Phidynamic, Phistatic, and Phitotal-Meal by SiMeal. Similarly, three different disposition indexes were calculated after intravenous glucose injection, by multiplying Phi1, Phi2, and Phitotal-IVGTT by SiIVGTT. Disposition index Phi1 x SiIVGTT is analogous to that proposed previously as the product of the acute insulin response by SiIVGTT (27–29), because Phi1 is a model-derived index of insulin secretion in response to the glucose increase observed immediately after the intravenous glucose administration.

Insulin clearance and hepatic insulin extraction.
Exogenous insulin administration during the intravenous glucose injection allowed calculation of total body insulin clearance by using the minimal model of posthepatic insulin secretion and insulin kinetics (44). The use of this model, in conjunction with the minimal model of C-peptide secretion and kinetics, enabled calculation of the fraction of secreted insulin that is extracted by the liver after the intravenous glucose injection (45).

Calculations.
Values from -30 to 0 min were averaged and considered as basal. Area above basal was calculated using the trapezoidal rule. Parameters of all models were estimated by using the SAAMII software (46). Measurement error of C-peptide concentration has been assumed to be independent and gaussian, with zero mean and with either a constant coefficient of variation equal to 1.5% (glucose data) or a constant but unknown variance (C-peptide and insulin data). Details of model identification have been previously described (37,39–41,44).

Statistical analysis.
Data are presented as mean ± SE. Two sample comparisons between the elderly and young participants were made using t tests or rank-sum tests for data that were not normally distributed. Phitotal-IVGTT and human growth hormone were transformed to the natural log scale because of skewness. Pearson’s or Spearman’s r was used to evaluate univariate correlations. All predictors were considered in a forward stepwise model selection process using multiple linear regression to determine significant multivariate predictors. Model r’s are reported as an indicator of model fit. Partial r’s are reported as an indicator of the contribution of single variables to the overall model. Age was used as an indicator of elder or young status. P < 0.05 was considered to be statistically significant.


   RESULTS
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Patient characteristics.
By design, the elderly participants were older than the young participants (70.1 ± 0.7 vs. 23.7 ± 0.8 years). Weight (79.6 ± 1.9 vs. 73.4 ± 3.0 kg), lean body mass (48.5 ± 1.4 vs. 48.5 ± 2.5 kg), and serum creatinine (1.1 ± 0.01 vs. 1.1 ± 0.0) did not differ in the elderly and young participants. However, the elderly participants had a greater BMI (27.5 ± 0.5 vs. 25.0 ± 0.6 kg/m2; P < 0.01), percentage body fat (33.6 ± 1.1 vs. 28.9 ± 1.7%; P < 0.05), and visceral fat (172 ± 12 vs. 62 ± 12 cm2; P < 0.001) than did the younger participants. VO2max (24.0 ± 0.8 vs. 42.5 ± 2.6 ml · kg-1 · min-1) and double knee extension (85.3 ± 3.7 vs. 138.8 ± 10.8 lb) were lower (P < 0.001) in the elderly than in the young participants (Table 1).


View this table:
[in this window]
[in a new window]
  		TABLE 1 Participant characteristics

 
Plasma glucose, insulin, and C-peptide concentrations in response to ingestion of a mixed meal.
Plasma glucose concentrations were higher (P < 0.001) in the elderly than in the young participants before meal ingestion (5.2 ± 0.04 vs. 4.8 ± 0.16 mmol/l) and increased to a higher (P < 0.001) peak (11.0 ± 0.2 vs. 9.5 ± 0.2 mmol/l) after meal ingestion (Fig. 1A). This resulted in a greater (P < 0.001) integrated response above basal in the elderly than in the young participants (521 ± 26 vs. 341 ± 34 mmol · l-1 · 7 h-1).



View larger version (15K):
[in this window]
[in a new window]
  		FIG. 1. Glucose (A), insulin (B), and C-peptide (C) concentrations observed in the elderly ({blacksquare}) and the young ({circ}) participants. A mixed meal was ingested at 0 min.

 
Neither fasting (28 ± 2 vs. 21 ± 1 pmol/l) nor peak postprandial (510 ± 36 vs. 440 ± 38 pmol/l) plasma insulin concentration differed in the elderly and young participants (Fig. 1B). However, the integrated response above basal was greater (P < 0.01) in the elderly than in the young participants (51.8 ± 3.8 vs. 33.4 ± 3.3 nmol · l-1 · 7 h-1). Of note, although the overall response was greater, the increase in plasma insulin above basal immediately after meal ingestion was lower (P < 0.01) in the elderly than in the young participants during the first 20 min (773 ± 84 vs. 1,287 ± 186 pmol · l-1 · 20 min-1).

Despite no differences in fasting insulin concentrations, fasting C-peptide concentrations were higher (P < 0.01) in the elderly than in the young participants (0.51 ± 0.02 vs. 0.38 ± 0.02 nmol/l) (Fig. 1C). Peak postprandial (3.4 ± 0.16 vs. 2.6 ± 0.15 nmol/l) and the integrated C-peptide response above basal also were greater (P < 0.01) in the elderly than in the young participants (489 ± 23 vs. 278 ± 19 nmol · l-1 · 7 h-1). As with insulin, the increase in plasma C-peptide above basal immediately after meal ingestion was lower (P < 0.02) in the elderly than in the young participants during the first 20 min after meal ingestion (3.4 ± 0.4 vs. 5.2 ± 0.8 nmol/l).

Plasma glucagon, cortisol, growth hormone, and palmitate concentrations in response to ingestion of a mixed meal.
Plasma glucagon concentrations (Fig. 2A) were higher (P < 0.002) in the elderly than in the young participants before meal ingestion (71 ± 3 vs. 54 ± 4 pg/ml) and increased to a higher peak (P < 0.01) after meal ingestion (105 ± 4 vs. 82 ± 6 pg/ml). In contrast, plasma cortisol concentrations (Fig. 2B) were lower (P < 0.01) in the elderly than in the young participants before meal ingestion (10.6 ± 0.3 vs. 13.7 ± 1.2 µg/dl) and increased to a lower peak (P < 0.05) after meal ingestion (16.0 ± 0.5 vs. 19.1 ± 1.4 µg/dl). Plasma growth hormone concentrations did not differ in the elderly and young participants before meal ingestion (0.7 ± 0.1 vs. 1.2 ± 0.3 ng/ml) and fell comparably immediately after meal ingestion (Fig. 2C). Plasma growth hormone concentrations subsequently rose as glucose concentrations fell toward basal levels in both groups; however, the postprandial peak was lower (P < 0.001) in the elderly than in the young participants (2.2 ± 0.2 vs. 6.2 ± 1.0 ng/ml).



View larger version (15K):
[in this window]
[in a new window]
  		FIG. 2. Glucagon (A), cortisol (B), and growth hormone (C) concentrations observed in the elderly ({blacksquare}) and the young ({circ}) participants. A mixed meal was ingested at 0 min.

 
Plasma palmitate concentrations were higher (P < 0.05) in the elderly than in the young participants before meal ingestion (108 ± 4 vs. 95 ± 5 µmol/l). Plasma palmitate fell to the same nadir in both groups after meal ingestion (Fig. 3A). This resulted in a greater (P < 0.01) suppression below basal in the elderly than in the young participants (-17.0 ± 0.7 vs. -14.6 ± 1.1 mmol · l-1 · 4 h-1).



View larger version (13K):
[in this window]
[in a new window]
  		FIG. 3. Plasma palmitate concentrations observed in the elderly ({blacksquare}) and the young ({circ}) participants after either ingestion of a mixed meal (A) or intravenous injection of glucose (B).

 
Plasma glucose, insulin, and C-peptide and palmitate concentrations in response to intravenous injection of glucose.
Plasma glucose concentrations (Fig. 4A) were higher (P < 0.001) in the elderly than in the young participants before intravenous glucose injection (5.2 ± 0.0 vs. 4.8 ± 0.1 mmol/l) and increased to a higher (P < 0.01) peak after intravenous glucose injection (19.0 ± 0.4 vs. 16.1 ± 0.8 mmol/l). This resulted in a greater increase (P < 0.01) in plasma glucose concentration above basal (236.7 ± 10.5 vs. 179.7 ± 14.6 mmol · l-1 · 4 h-1). The increase in plasma glucose above basal during the first 20 min after glucose injection (i.e., before injection of exogenous insulin) also was greater (P < 0.05) in the elderly than in the young participants (168.2 ± 3.1 vs. 145.0 ± 9.5 mmol · l-1 · 20 min-1).



View larger version (14K):
[in this window]
[in a new window]
  		FIG. 4. Glucose (A), insulin (B), and C-peptide (C) concentrations observed in the elderly ({blacksquare}) and the young ({circ}) participants. Intravenous glucose was injected at 0 min, and exogenous insulin was injected at 20 min.

 
Plasma insulin concentrations did not differ in the elderly and the young participants before glucose injection (27.7 ± 1.8 vs. 23.9 ± 1.6 pmol/l). Insulin concentrations increased in the elderly and the young participants immediately after glucose injection. The peak (346 ± 26 vs. 437 ± 59 pmol/l) and area above basal during the first 20 min after intravenous glucose injection (2.9 ± 0.2 vs. 3.6 ± 0.5 nmol/l) was slightly but not significantly lower in the elderly than in the young participants (Fig. 3B). The increase in plasma insulin after injection of exogenous insulin at 20 min did not differ between groups.

Despite no differences in fasting insulin concentrations, plasma C-peptide concentrations were higher (P < 0.02) in the elderly than in the young participants (0.55 ± 0.02 vs. 0.45 ± 0.02 nmol/l) before glucose injection (Fig. 4C). Plasma C-peptide concentrations promptly rose in both groups after glucose injection. Peak C-peptide concentrations (1.72 ± 0.07 vs. 2.00 ± 0.2 nmol/l) and the area above basal during the first 20 min after glucose injection (14.4 ± 0.8 vs. 18.4 ± 2.2 nmol/l) were slightly but not significantly lower in the elderly than in the young participants. Conversely, plasma C-peptide concentrations were higher in the elderly than in the young participants from 20 min onward, resulting in a greater (P < 0.01) overall integrated response (70.9 ± 4.9 vs. 42.8 ± 6.0 nmol · l-1 · 4 h-1).

Plasma palmitate concentrations were higher (P < 0.01) in the elderly than in the young participants (86 ± 3 vs. 66 ± 3 µmol/l) before intravenous glucose injection (Fig. 3B). Plasma palmitate concentrations fell to the same nadir in both groups after glucose injection (Fig. 3B). This resulted in greater (P < 0.01) suppression below basal in the elderly than in the young subjects (-6.7 ± 0.5 vs. 3.9 ± 1.0 mmol · l-1 · 3 h-1).

Indexes of insulin action and secretion.
Insulin action (Si) can be measured with both the meal and intravenous glucose minimal models (Fig. 5). Si was lower in the elderly than in the young participants after both meal ingestion (16.2 ± 1.1 vs. 24.8 ± 2.1 dl · kg-1 · min-1 per pmol/l; P < 0.002) and glucose injection (6.3 ± 0.5 vs. 10.4 ± 0.8 10-5 min-1 per pmol/l; P < 0.001). Sg (an index of glucose effectiveness), measured after intravenous glucose injection, did not differ in the elderly and the young participants (1.8 ± 0.0 vs. 1.9 ± 0.1 10-2/min).



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 5. Insulin action (Si) measured in the elderly and the young participants with the meal (A) and intravenous glucose (B) minimal models. *P < 0.002.

 
Insulin secretion indexes after meal ingestion (Phidynamic, Phistatic, and Phitotal-Meal) all tended to be lower in the elderly than in the young participants (Fig. 6); however, only Phitotal-Meal was statistically significant (P < 0.05). First-phase insulin secretion index after glucose injection, Phi1, and the natural log of Phitotal-IVGTT were lower (P < 0.05) in the elderly than in the young participants. Phi2 did not differ between groups.



View larger version (27K):
[in this window]
[in a new window]
  		FIG. 6. Insulin secretion indexes obtained with the meal (left panels) and intravenous glucose (right panels) minimal models. *P < 0.05.

 
All disposition indexes, which adjust insulin secretion for insulin action, were lower (P < 0.01) in the elderly than in the young participants after both meal ingestion and glucose injection (Fig. 7). This was true regardless of whether the disposition index was calculated as Phidynamic, Phistatic, or Phitotal-Meal times SiMeal using the meal minimal model or Phi1, Phi2, or Phitotal-IVGTT times SiIVGTT using the intravenous minimal model.



View larger version (30K):
[in this window]
[in a new window]
  		FIG. 7. Disposition indexes in the elderly and the young participants calculated by multiplying insulin secretion indexes and insulin action indexes obtained from the meal (left panels) and intravenous glucose (right panels) minimal models. *P < 0.01.

 
Insulin clearance and hepatic insulin extraction.
Total body insulin clearance was lower (P < 0.002) in the elderly than in the young participants (Fig. 8). In contrast, hepatic insulin extraction was greater in the elderly than in the young participants whether measured as basal, i.e., before glucose injection (P < 0.001), or after glucose injection (P < 0.002).



View larger version (20K):
[in this window]
[in a new window]
  		FIG. 8. Total body insulin clearance (A) and hepatic insulin extraction (B) calculated in the elderly and the young participants using the intravenous glucose minimal model. *P < 0.01.

 
Multivariate analyses of meal and intravenous minimal model indexes.
Although the meal and intravenous glucose minimal models both assess insulin secretion, they do so in response to different stimuli administered by different routes. It therefore was of interest that Si measured with the meal minimal model (Fig. 9) was correlated with Si measured with the intravenous glucose minimal model (r = 0.72; P < 0.001). In addition, Phidynamic, Phistatic, and Phitotal measured with the meal minimal model were correlated respectively with Phi1 (r = 0.45; P < 0.001), Phi2 (r = 0.67; P < 0.001), and Phitotal (r = 0.67; P < 0.001) measured with the intravenous glucose model (Fig. 10).



View larger version (13K):
[in this window]
[in a new window]
  		FIG. 9. Correlations between insulin action indexes obtained with the meal (SiMeal) and intravenous (SiIVGTT) minimal models measured in the elderly ({blacksquare}) and the young ({circ}) participants.

 


View larger version (16K):
[in this window]
[in a new window]
  		FIG. 10. A–C: Correlations between insulin secretion indexes obtained with the meal (PhiMeal) and intravenous (PhiIVGTT) minimal models measured in the elderly ({blacksquare}) and the young ({circ}) participants.

 
Univariate analyses indicated that insulin action measured with the meal minimal model (i.e., SiMeal) was significantly correlated with percentage body fat (r = -0.60; P < 0.001), visceral fat (r = -0.35; P < 0.001), double knee extension (r = 0.34; P < 0.01), VO2max (r = 0.36; P < 0.001), and fasting glucose (r = -0.31; P < 0.01). However, when these factors, as well as age and sex, were included in a multivariate model (r = 0.68; P < 0.0001), only percentage body fat (partial r = 0.58; P < 0.0001) and visceral fat (partial r = 0.28; P < 0.01) remained significant, suggesting that the degree of fatness rather than age per se, leg strength, or aerobic fitness was the primary determinant of insulin action. Similarly, univariate analyses indicated that insulin action measured with the intravenous minimal model (i.e., SiIVGTT) was significantly correlated with percentage body fat (r = -0.44; P < 0.001), visceral fat (r = -0.49; P < 0.001), fasting glucose (r = -0.35; P < 0.001), and total insulin clearance (r = 0.34; P < 0.01). However, when these factors, as well as age and sex, were included in a multivariate model (r = 0.63; P < 0.001), only percentage body fat (partial r = 0.42; P < 0.001) and visceral fat (partial r = 0.41; P < 0.001) remained significant, again suggesting that degree of fatness rather than age per se was the primary determinant of insulin action.

Postprandial glucose tolerance for a given individual is determined by multiple factors, including his or her ability to secrete and respond to insulin. Univariate analysis indicated that Phitotal-Meal (r = -0.30; P < 0.01), Phistatic (r = -0.25; P < 0.05), SiMeal (r = -0.49; P < 0.001), VO2max (r = -0.36; P < 0.001), and double knee extension (r = -0.39; P < 0.001) were significantly correlated with the meal glycemic response above basal.

When these factors, as well as age, were included in a multivariate analysis (r = 0.68; P < 0.001), only SiMeal (partial r = 0.51; P < 0.0001) and Phitotal-Meal (partial r = 0.45; P < 0.0001) remained significant. Multivariate analysis (r = 0.53; P < 0.001) indicated that indexes of insulin secretion (Phitotal-IVGTT) and action (SiIVGTT) derived during the intravenous glucose tolerance tests also correlated with the meal glycemic response above basal (partial r = 0.29, P < 0.01; and partial r = 0.26, P < 0.05, respectively). However, neither of these parameters remained significant when the corresponding meal indexes were included in the same multivariate model.


   DISCUSSION
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Glucose tolerance decreases with age. The present data indicate that defects in both insulin secretion and action contribute to this decline. Insulin action, measured with either the meal or the intravenous glucose minimal models, was lower in the elderly than in the young participants. Insulin secretion was also impaired in the elderly individuals. When considered in light of the degree of insulin resistance, all indexes of insulin secretion were decreased in the elderly participants, indicating decreased ß-cell secretory reserve. Although total body insulin clearance was lower in the elderly than in the young subjects, hepatic insulin extraction was higher, thereby limiting the amount of insulin that reached extrahepatic tissues. Cortisol and growth hormone did not seem to contribute to the age-associated decline in postprandial insulin action because concentrations of these hormones were lower in the elderly than in the young participants after meal ingestion. However, both glucagon concentrations and body fat (visceral as well as total) were higher in the elderly than in the young participants, whereas VO2max (an index of aerobic fitness) was lower. However, addition of these factors to a model that already included indexes of insulin secretion and action did not further improve the ability of the model to predict the postprandial glycemic response.

Many (1–6) but not all (7–11) previous studies have reported that elderly subjects are insulin resistant. The current study extends these findings by showing that insulin action is lower in elderly participants after both mixed-meal ingestion and glucose injection. Because insulin action with these two approaches was measured on different days and calculated using entirely different datasets, concordant and comparable decreases in elderly participants with both tests strongly supports the conclusion that elderly individuals are more insulin resistant than younger individuals. Of perhaps greater interest, not only was the magnitude of the decrease comparable with the two methods, but also insulin action measured with the meal minimal model correlated with that determined in the same individual with the IVGTT minimal model. This supports the contention that insulin action assessed using the "cold" minimal model during an intravenous glucose tolerance test reflects insulin action present under more physiologic conditions such as occurs after eating a meal. The strength of the correlation also argues against an effect of factors uniquely present after meal ingestion (e.g., incretins) on insulin action.

The cause of insulin resistance in the elderly has been a matter of active debate. Consistent with previous reports (2,6,22,47), the elderly individuals in the present study had a greater percentage body fat, more visceral fat, a lower level of aerobic fitness as measured by a VO2max, and less leg strength as measured by the double knee extension than did the younger comparison group. After adjustment for these factors using multivariate analysis, insulin action no longer differed in the elderly and the young groups. This observation supports previous reports (2,6) that insulin action measured with either an IVGTT or a euglycemic-hyperinsulinemic clamp did not differ in elderly and young subjects when adjusted for BMI or waist-to-hip ratio, respectively. It is interesting that the strongest determinant of insulin action in the present study seemed to be body fat. Although VO2max and double knee extension also predicted insulin action, these effects became nonsignificant when adjusted for percentage body fat and visceral fat. However, correlations do not prove causality. They therefore do not rule out an independent effect of age per se or a possible effect of relative androgen deficiency because the elderly volunteers were selected for testosterone and DHEA levels in the lower range of normal. They also do not contradict the well-established beneficial effects of exercise undertaken by previously sedentary individuals on insulin action (8,11,22,47) because the present studies assessed the relationship between insulin action and the level of fitness in the untrained state rather than the response to aerobic training. Nevertheless, the present data add further support to the concept that the degree of fatness is an important determinant of insulin action in the elderly.

The effects of age on ß-cell function has been a matter of debate with previous investigators reporting an increase (2,15,16), decrease (1,7,8,11,14), or no change (3,4,10,12,13) in insulin secretion in the elderly. These discordant results likely have been due in large part to the differences in methods used to assess insulin secretion. In the present studies, fasting insulin concentrations did not differ in the elderly and the young participants on either the meal or the intravenous glucose study days. However, fasting C-peptide concentration were significantly higher in the elderly than in the young individuals on both study days, indicating that an increase in insulin secretion was offset by a concomitant increase in hepatic insulin extraction. This was confirmed by the intravenous minimal model that showed that hepatic insulin extraction was higher in the elderly than in the young participants both before and after glucose injection.

Although decreased C-peptide clearance as a result of impaired renal function potentially could have influenced the fasting insulin–to–C-peptide ratio, we believe this to be unlikely. Plasma creatinine concentrations in these healthy elderly participants did not differ from those observed in the young participants, indicating at most a minimal decrease in renal function. Furthermore, the C-peptide model used to calculate insulin secretion and hepatic insulin clearance during the IVGTT minimal model uses the C-peptide kinetic data of Van Cauter et al. (42) that explicitly takes into account age-associated changes in C-peptide clearance. Decreased total body insulin clearance and increased hepatic insulin extraction have been reported by other investigators, albeit often assessed using different methods in different individuals (7,48,49). The opposite changes in total body and hepatic insulin extraction observed in the elderly individuals in the present study are intriguing because they suggest compensatory changes and indicate that hepatic and extrahepatic insulin metabolism are differentially regulated. The latter may be due to differences in liver and vascular insulin proteases and/or insulin receptor binding. The present data also emphasize the need to use C-peptide in conjunction with validated models to measure insulin secretion rather than merely measure peripheral insulin concentrations.

Multiple facets of insulin secretion were abnormal in the elderly participants. The increase in plasma C-peptide concentrations immediately after either meal ingestion or intravenous glucose injection tended to be lower in the elderly than in the young participants. C-peptide concentrations subsequently became higher in the elderly presumably as a result of the higher prevailing glucose concentrations. Calculation of the various indexes of insulin secretion indicated that Phitotal-Meal, Phi1, Phi1-IVGTT, and Phitotal-IVGTT were lower in the elderly participants. However, when considered in light of the degree of insulin resistance as reflected by the disposition index, all indexes of insulin secretion were lower in the elderly participants, indicating a global defect in insulin secretion. This conclusion is consistent with the demonstration by Meneilly et al. (50) that normal aging is associated with a reduction in both mass and amplitude of the rapid insulin pulses that occur during intravenous glucose infusion. First-phase insulin secretion after intravenous glucose injection is believed to be primarily determined by the rate of exocytosis of previously docked insulin granules (51,52). In contrast, second-phase insulin secretion is believed to be determined by multiple factors, including the rate of new insulin synthesis, insulin granule translocation, and membrane fusion (51,52). Experimental reduction of ß-cell mass decreases both early and late insulin secretion (53). However, although an age-related decrease in ß-cell mass could account for the alterations in insulin secretion, it is unlikely to explain the increase in hepatic insulin extraction observed in the present study because partial pancreatectomy results in a decrease (rather than an increase) in hepatic insulin extraction (54).

Both fasting and postprandial glucose concentrations were higher in the elderly than in the young participants. Multivariate analysis indicated that ~45% of the postprandial glycemic response could be explained by the indexes of insulin action and secretion, indicating that the variables being assessed by both the meal and the IVGTT minimal models are physiologically relevant. However, not surprising, the strength of the prediction was greater with the meal as evident by the fact that the IVGTT indexes were no longer significant when the meal indexes were included in the model. These data indicate that although the IVGTT minimal model is useful in predicting the glycemic response to a mixed meal in the same individual, the meal minimal model is better. Essentially the same relationship was observed when peak postprandial glucose concentration rather than the postprandial glycemic response (i.e., area above basal) was used as the dependent variable (data not shown). Addition of pre- or postprandial glucagon, cortisol, or growth hormone concentrations to the model did not improve the ability of the model to predict the postprandial glycemic response. This observation argues against a role for these hormones in the glucose intolerance of the elderly.

In summary, the present studies provide a comprehensive assessment of glucose tolerance in the elderly. They indicate that both fasting and postprandial glucose concentrations are higher in elderly than in young subjects. These alterations in glucose tolerance are associated with defects in insulin action, secretion, and clearance. The severity of the reduction in insulin action is in large part explained by percentage body fat and visceral fat indicating that both obesity and the site of the fat seem to be the major determinants of insulin action in elderly as well as young individuals. Comparable decreases in insulin secretion are evident after both meal ingestion and glucose injection, suggesting an intrinsic alteration in ß-cell function rather than an age-related alteration in the response to nutrients or incretins. Hepatic insulin extraction is greater in the elderly than in the young participants, suggesting an alteration in hepatic insulin action and/or metabolism. Conversely, total body insulin clearance is lower, suggesting a concomitant and perhaps compensatory alteration in extrahepatic insulin metabolism.

The elderly participants in the present studies were less fit, weaker, and more obese than the younger control group. Therefore, the present study did not assess the effects of aging per se but rather the effects of the physical changes associated with aging. Perhaps more important, the elderly participants were specifically selected to have low normal DHEA (in the men and women) and testosterone (in the men) concentrations, reflecting the hormonal milieu present in a large number of otherwise healthy older individuals. It will be of considerable interest to determine the extent to which replacement of these hormones ameliorates or reverses these defects in carbohydrate tolerance.


   ACKNOWLEDGMENTS
 
This study was supported by the U.S. Public Health Service (AG 14383, RR-00585, and P41 EB-001975), a Novo Nordisk research infrastructure grant, the Ministero dell’Università e della Ricerca Scientifica e Tecnologica, Italy, and the Mayo Foundation. R.B. was supported by an American Diabetes Association Mentor–based fellowship.

We thank R. Rood, B. Dicke, J. Feehan, B. Norby, M. Otte, T. Hammer, and L. Wahlstrom for technical assistance and assistance in recruiting the participants, M. Davis for assistance in the preparation of the manuscript, and the staff of the Mayo General Clinical Research Center for assistance in performing the studies. We also thank our coinvestigators on the program project, including Drs. Sree Nair, Sundeep Khosla, Peter O’Brien, and Donald Tindall, for thoughtful comments and suggestions.

Address correspondence and reprint requests to Robert A. Rizza, MD, Mayo Clinic Rochester, 200 First St. SW, Rm. 5-194 Joseph, Rochester, MN 55905. E-mail: rizza.robert{at}mayo.edu

Received for publication December 4, 2002 and accepted in revised form March 21, 2003

Abbreviations: Bio T, bioavailable testosterone; IVGTT, intravenous glucose tolerance test; VO2max, peak oxygen uptake


   REFERENCES
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Chen M, Bergman RN, Pacini G, Porte D Jr: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased ß-cell function. J Clin Endocrinol Metab60 :13 –20,1985[Abstract]
  2. Coon PJ, Rogus EM, Drinkwater D, Muller DC, Goldberg AP: Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab75 :1125 –1132,1992[Abstract]
  3. DeFronzo RA: Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes28 :1095 –1101,1979[Medline]
  4. O’Shaughnessy IM, Kasdorf GM, Hoffmann RG, Kalkhoff RK: Does aging intensify the insulin resistance of human obesity? J Clin Endocrinol Metab74 :1075 –1081,1992[Abstract]
  5. Rowe JW, Minaker KL, Pallotta JA, Flier JS: Characterization of the insulin resistance of aging. J Clin Invest71 :1581 –1587,1983
  6. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U: European Group for the Study of Insulin Resistance (EGIR): insulin action and age. Diabetes45 :947 –953,1996[Abstract]
  7. Ahren B, Pacini G: Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J Clin Endocrinol Metab83 :3350 –3356,1998[Abstract/Free Full Text]
  8. Pacini G, Valerio A, Beccaro F, Nosadini R, Cobelli C, Crepaldi G: Insulin sensitivity and beta-cell responsivity are not decreased in elderly subjects with normal OGTT. J Am Geriatr Soc36 :317 –323,1988[Medline]
  9. Boden G, Chen X, DeSantis RA, Kendrick Z: Effects of age and body fat on insulin resistance in healthy men. Diabetes Care16 :728 –733,1993[Abstract]
  10. Broughton DL, James OWF, Alberti KGMM, Taylor R: Peripheral and hepatic insulin sensitivity in healthy elderly human subjects. Eur J Clin Invest21 :13 –21,1991[Medline]
  11. Dechenes CJ, Verchere CB, Andrikopoulos S, Kahn SE: Human aging is associated with parallel reductions in insulin and amylin release. Am J Physiol Endocrinol Metab275 :E785 –E791,1998[Abstract/Free Full Text]
  12. Bourey RE, Kohrt WM, Kirwan JP, Staten MA, King DS, Holloszy JO: Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontol48 :M122 –M127,1993[Medline]
  13. Elahi D, Muller DC, McAloon-Dyke M, Tobin D, Andres R: The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus. Exp Gerontol28 :393 –409,1993[Medline]
  14. Pacini G, Beccaro F, Valerio A, Nosadini R, Crepaldi G: Reduced beta-cell secretion and insulin hepatic extraction in healthy elderly subjects. J Am Geriatr Soc38 :1283 –1289,1990[Medline]
  15. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechtel G, Fink RI: Effects of aging on insulin secretion. Diabetes38 :1549 –1556,1989[Abstract]
  16. Jackson RA, Hawa MI, Roshania RD, Sim BM, DiSilvio L, Jaspan JB: Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes36 :119 –129,1988
  17. Dowse GK, Zimmet PZ, Alberti KGMM, Brigham L, Carlin JB, Tuomilehto J, Knight LT, Gareeboo H: Serum insulin distributions and reproducibility of the relationship between 2-hour insulin and plasma glucose levels in Asian Indian, Creole, and Chinese Mauritians. Metabolism42 :1232 –1241,1993[Medline]
  18. Shapiro ET, Tillil H, Miller MA, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS: Insulin secretion and clearance: comparison after oral and intravenous glucose. Diabetes36 :1365 –1371,1987[Abstract]
  19. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W: Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab76 :912 –917,1993[Abstract]
  20. Zander M, Madsbad S, Madsen JL, Holst JJ: Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and ß-cell function in type 2 diabetes: a parallel-group study. Lancet359 :824 –830,2002[Medline]
  21. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH: Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest78 :1648 –1657,1986
  22. Miller JP, Pratley RE, Goldberg AP, Gordon P, Rubin M, Treuth MS, Ryan AS, Hurley BF: Strength training increases insulin action in healthy 50- to 65-yr-old men. J Appl Physiol77 :1122 –1127,1994[Abstract/Free Full Text]
  23. Kirwan JP, Kohrt WM, Wojta DM, Bourey RE, Holloszy JO: Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol Med Sci48 :M84 –M90,1993
  24. Rizza R, Mandarino L, Gerich J: Cortisol induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metab54 :131 –138,1982[Abstract]
  25. Rizza RA, Mandarino LJ, Gerich JE: Effect of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes31 :663 –669,1982[Abstract]
  26. Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA: Assessment of hepatic sensitivity to glucagon in NIDDM. Diabetes46 :2007 –2016,1997[Abstract]
  27. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JP, Palmer JP, Port DJ: Quantification of the relationship between insulin sensitivity and ß-cell function in human subjects: evidence for a hyperbolic function. Diabetes42 :1663 –1672,1993[Abstract]
  28. Bergman RN: Toward physiological understanding of glucose tolerance: the minimal model approach. Lilly Award Lecture. Diabetes38 :1512 –1527,1989[Abstract]
  29. Bergman RN, Ader M, Huecking K, Van Citters G: Accurate assessment of B-cell function: the hyperbolic correction. Diabetes51 (Suppl. 1) :S212 –S220,2002[Abstract/Free Full Text]
  30. Vermeulen A, Kaufman JM, Giagulli VA: Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab81 :1821 –1826,1996[Abstract]
  31. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab86 :724 –731,2001[Abstract/Free Full Text]
  32. Miles JM, Ellman MG, McClean KL, Jensen MD: Validation of a new method for the determination of free fatty acid turnover. Am J Physiol252 :E431 –E438,1987
  33. Jensen MD, Kanaley JA, Reed JE, Sheedy PF: Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr61 :274 –278,1995[Abstract/Free Full Text]
  34. Proctor DN, Sinning WE, Walro JM, Sieck GC, Lemon PW: Oxidative capacity of human muscle fiber types: effects of age and training status. J Appl Physiol78 :2033 –2038,1995[Abstract/Free Full Text]
  35. Taafe DR, Marcus R: Dynamic muscle strength alterations to detraining and retraining in elderly men. Clin Physiol17 :311 –324,1997[Medline]
  36. Dalla Man C, Caumo A, Cobelli C: The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng49 :419 –429,2002[Medline]
  37. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C: Oral glucose tolerance test minimal model indexes of ß-cell function and insulin sensitivity. Diabetes50 :150 –158,2001[Abstract/Free Full Text]
  38. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab284 :E55 –E69,2003[Abstract/Free Full Text]
  39. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol236 :E667 –E677,1979
  40. Toffolo G, De Grandi F, Cobelli C: Estimation of ß-cell sensitivity from intravenous glucose tolerance tests C-peptide data. Diabetes44 :845 –854,1995[Abstract]
  41. Toffolo G, Cefalu WT, Cobelli C: ß-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model. Metabolism48 :1162 –1166,1999[Medline]
  42. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes41 :368 –377,1992[Abstract]
  43. Bergman RN, Phillips SP, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest68 :1456 –1467,1981
  44. Toffolo G, Arduini A, De Zanche N, Avogaro A, Cobelli C: A minimal model of insulin during insulin modified IVGTT: assessment of hepatic insulin extraction. In Proceedings of the 3rd IFAC Symposium on Modeling and Control in Biomedical Systems. Linkens DA, Carson E, Eds. Elsevier, Amsterdam,1997 , p.91 –95
  45. Toffolo G, Cobelli C: Insulin modelling. In Modelling Methodology for Physiology and Medicine. Carson E, Cobelli C, Eds. London, UK, Academic Press,2001 , p.305 –333
  46. Barret PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster D: SAAM II: simulation, analysis and modeling software for tracer and pharmacokinetic studies. Metabolism47 :484 –492,1998[Medline]
  47. Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Holloszy JO: Glucose tolerance in young and older athletes and sedentary men. Am J Physiol56 :1521 –1525,1984
  48. Fink RI, Revers RR, Kolterman OG, Olefsky JM: The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging. Diabetes34 :275 –280,1985[Abstract]
  49. Minaker KL, Rowe JM, Tonino R, Pallotta JA: Influence of age on clearance of insulin in man. Diabetes31 :851 –855,1982[Abstract]
  50. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D: Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab82 :4088 –4093,1997[Abstract/Free Full Text]
  51. Meneilly GS, Veldhuis JD, Elahi D: Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab84 :1938 –1943,1999[Abstract/Free Full Text]
  52. Halban PE: Differential rates of release of newly synthesized and of stored insulin from pancreatic islets. Endocrinology110 :1183 –1188,1982[Medline]
  53. Draznin B, Steinberg JP, Goodman M, Leitner JW, Sussman KE: Control of secretion vesicle margination and lysis by glucose, IBMX, and glyburide. Am J PhysiolE375 –E380,1985
  54. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang D, Lefebvre P, Butler PC: Decrease in ß-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes50 :2001 –2012,2001[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Gavi, J. J. Feiner, M. M. Melendez, D. C. Mynarcik, M. C. Gelato, and M. A. McNurlan
Limb Fat to Trunk Fat Ratio in Elderly Persons Is a Strong Determinant of Insulin Resistance and Adiponectin Levels
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2007; 62(9): 997 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Basu, C. D. Man, M. Campioni, A. Basu, K. S. Nair, M. D. Jensen, S. Khosla, G. Klee, G. Toffolo, C. Cobelli, et al.
Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly Men
Diabetes Care, August 1, 2007; 30(8): 1972 - 1978.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F. Escriva, M L. Gavete, Y. Fermin, C. Perez, N. Gallardo, C. Alvarez, A. Andres, M. Ros, and J. M Carrascosa
Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity
J. Endocrinol., July 1, 2007; 194(1): 131 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
R. Stevic, T. B. Zivkovic, P. Erceg, D. Milosevic, N. Despotovic, and M. Davidovic
Oral glucose tolerance test in the assessment of glucose-tolerance in the elderly people
Age Ageing, July 1, 2007; 36(4): 459 - 462.
[Full Text] [PDF]

Home page
 DiabetesHome page
G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza
Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes
Diabetes, April 1, 2007; 56(4): 1113 - 1119.
[Abstract] [Full Text] [PDF]